This invention relates to tubular medical prostheses that are expandable from a radially compact disposition to a radially expanded disposition. In the compact disposition, the prosthesis can by delivered to its operational site in the body, typically trans-luminally and percutaneously, using a delivery system which is a sort of catheter. Exemplary of this class of prosthesis is a nickel titanium shape memory alloy stent for a bodily lumen which is often but not always an arterial lumen. See for example the disclosure of applicant's earlier WO 01/32102.
Bodily soft tissue is remarkably flexible and needs generally to be flexible. It is difficult for a metal stent to match bodily tissue for flexibility. WO 01/32102 is concerned with flexibility of the stent during its journey, from outside the body to the operational site within the body, as for example the catheter delivery system advances along a tortuous path from the point of entry in the body. However, there is also a need for metal stents (and other prostheses) that are destined to be installed at a location in the body where severe bending is to be expected. If the prosthesis could be made more tolerant of severe bending after placement, that would be attractive to doctors and their patients.
WO 01/32102 shows what could be termed a “classic” self-expanding stent structure of zig-zag stenting rings composed of struts interspersed by points of inflection and with adjacent stenting rings linked axially by connector portions. In the compact delivery disposition of the stent (FIG. 3 of WO 01/32102) the struts of the zig-zag rings are more or less parallel to each other so that each point of inflection represents a change of direction for the material of the stenting ring of more or less 180°. As the stent expands to its deployed configuration (FIG. 4 of WO 01/32102) the radius of the stenting ring expands by movement of the struts away from each other so that gaps open up between adjacent struts, and the adjacent points of inflection move further apart (but nevertheless remain spaced at equal intervals to each other around the circumference of the stenting ring).
The connectors serve to restrain relative circumferential movement of the zig-zag rings relative to each other. Thus, if the points of inflection of adjacent stenting rings are facing each other in the compact delivery disposition of the stent, as in WO 01/32102, then so will be these points of inflection still facing each other in the expanded disposition of the stent. When an expanded stent is subject, in the body, to extreme bending, so that the longitudinal axis of the stent is no longer a straight line but a pronounced curve (as in a banana), then the facing points of inflection on the inside of the bend approach each other. The more extreme the bending, the closer the facing points of inflection become until, in the end, these facing “peaks” abut each other or rub past each other.
Any such abutment or rubbing is undesirable. One way to guard against it is to choose a stent design that can be classified as a “peak-to-valley” design rather than a “peak-to-peak” design as seen in applicant's WO 01/32102. The art is replete with suggestions for peak-to-valley designs in which the peaks of any one zig-zag stenting ring do not face corresponding peaks of the next adjacent stenting ring but, instead, are circumferentially offset to the peaks of the next adjacent stenting ring by half of the gap between two adjacent peaks of the same ring, in the expanded disposition of the stent. Then, under extreme bending, any particular peak on the inside of the bend can advance into the V-shaped space between two peaks of the next adjacent stenting ring, without any abutment or rubbing on any portion of the material of the next adjacent stenting ring.
The present invention is concerned with the above-explained problem. It seeks to improve the in situ bend capability of stents including those seen in WO 01/32102. However, the invention also seeks to achieve this performance enhancement without sacrificing other attractive qualities of stents such as disclosed in WO 01/32102. For example, simplicity of modelling of stress distributions within the stent is attractive in the management of fatigue performance of metal stents. Manufacturing simplicity of course facilitates management of cost which should improve access to stents, for those people who need them.
Looking at WO 01/32102, one can quickly see that performance in extreme bending could be enhanced by extending the length of the portions that connect adjacent zig-zag stenting rings. The longer these “bridges” then the more the stent can bend without abutment of peaks on the inside of the bend. However, large axial gaps between adjacent stenting rings are not desirable, for then the tissue of the lumen that is being stented by the prosthesis is relatively unsupported, at least between adjacent stenting rings.
For the same reason, one seeks as far as possible to distribute the metallic material of the stent as evenly as possible over the length and circumference of the tubular envelope of the stent so that support for the stented tissue is as even and uninterrupted as possible. This of course indicates that all gaps between all adjacent struts and points of inflection of the stent matrix should be as constant as possible. Generally, one does not modulate the strut matrix of a stent, over the length and circumference of the stent, to suit tissue variations within the stenting site. Generally, one does not seek to place a particular point on the circumference of the stent in opposition to a particular zone of tissue within the stenting site. For these reasons alone, one seeks a stent matrix that is everywhere the same over the length and circumference of the prosthesis.
In principle, the problem addressed in the present invention, and the solution here disclosed, is useful in all classes of stenting prostheses. That is to say, it works with a stent matrix that exhibits the (spiral) turns around the axis of a helical stent, as well as with a stent that features a stack of endless stenting rings. It works with balloon-expandable stents and resilient self-expanding stents as well as with nickel titanium shape memory alloy stents.
Nevertheless, according to the present invention, it is contemplated to depart from the prior good design practice, and deliberately configure the stent matrix so that it is locally different, at one point at least, around the circumference of at least every second stenting ring within the prosthesis. In short, we envisage within each stenting ring at least one location (we call it a “stagger zone”) where the gap between adjacent points of inflection is smaller (but it could be greater) than the otherwise constant (or near constant) “wavelength” around the circumference of the prosthesis for that particular stenting ring.
It will be appreciated that, for any particular pair of adjacent stenting rings, even just one such abnormal gap (stagger zone) could be enough to set up a circumferential offset between the otherwise facing “peak-to-peak” points of inflection that we see in, for example, FIG. 4 of WO 01/32102. In practice, however, a design with only one stagger zone on the circumference might not be enough to deliver the desired circumferential offset all around the circumference, especially in designs that feature a large number of struts, in any one turn around the axis of the prosthesis. Four stagger zones are likely to be enough. Designs with two, three or four such zones are presently preferred, but up to 6 stagger zones per turn are readily conceivable, the more so with stent design with a notably small mesh size in their matrix.
As mentioned above, it is the connectors between adjacent stenting rings that prevent adjacent stenting rings from rotating around the long axis of the prosthesis relative to each other and thereby preserve the designed intended relationship between facing stenting rings and their respective points of inflection. Generally, it will be convenient to incorporate the design variation that creates the abnormal gap between adjacent points of inflection with the design of the connector zone between two adjacent turns. Thus, in perhaps the simplest case, we can envisage a connector from which two struts extend into a stenting ring or turn on one side of the connector, and two other struts extend in the other axial direction, into the next adjacent stenting ring or turn. If the angle between the first two struts is “normal” for that stenting ring, but the angle between the opposite pair of struts, in the other of the two stenting rings, is much smaller than “normal”, then the points of inflection circumferentially on either side of the connector, that would be facing each other in the classic construction of WO 01/32102, will be circumferentially offset from each other, because of the different angle of the struts each side of the connector. Think of the connector as the trunk of a human body, with the legs of the body slightly open and the two arms of the body. Imagine the angle between the upwardly outstretched arms significantly greater than the angle between the legs.
Rather than set out a string of statements of invention, and then repeat them in a set of claims, we opt for economy of text, refrain from reciting statements of invention, and present various aspects of the above explained inventive concept in claims appended to this description.
We have stated that setting up a “peak-to-valley” configuration of otherwise facing inflection zones is conveniently incorporated in the design of portions that connect adjacent stenting rings (or helical turns). However, one can readily envisage that the necessary offset can be created in a stagger zone that is circumferentially spaced from connectors. There is no imperative that the stagger zone must be coincident with the connector zone.
It will be evident that a stagger zone can be created in a number of different ways. One can locally manipulate the mechanical properties of the material of the stagger zone, not just be local modulation of the dimensions of the inflection points or struts within the stagger zone, relative to the rest of the circumference of the stenting ring, but could also contemplate manipulation of the mechanical properties of the material in the stagger zone by local heat treatment or even chemical treatment. It is even possible to envisage adding components to an otherwise “classic” stenting ring structure as in WO 01/32102, such as a flexible “tie” between the two struts that are destined to deliver a smaller than usual gap between adjacent points of inflection. When a painter erects an easel, there is a “piece of string” that runs between the front frame of the easel, and the rear strut of the easel, not far above the ground, where the gap between the front legs of the easel and the single rear leg of the easel rest on the ground. A classic stent such as shown in WO 01/32102 could be modified by inclusion in it of judiciously placed “pieces of string” from biologically compatible material, in order to restrain two adjacent struts of selected stenting rings of the prosthesis from opening to the full extent that occurs for all the other struts of that particular stenting ring. (We mention this possibility not with any expectation that it will be a preferred construction, but in the recognition that competitors stimulated by the present disclosure might be obliged to turn to such constructions in the hope of avoiding the inventive concept of the present application). The motto “keep it simple” is rather powerful and the present inventors are proud of a contribution to the art that is essentially simple but should deliver a powerful enhancement of performance.
At this juncture, it is worth noting that a shape memory alloy stent is given its “remembered” configuration by a heat treatment. In the case of WO 01/32102, that heat treatment is given with the points of inflection arranged “peak-to-peak”. With shape memory alloy stents embodying the present invention, however, the heat treatment is with the inflection points arranged as intended, therefore, not peak to peak, but in the circumferentially staggered arrangement brought about by the stagger zone(s).
In the context of the present invention, attention is directed to the disclosure of US/2004/0073290 and, in particular, drawings
Thinking about the bend capability of any particular stent design, this might be limited by peak to peak abutment on the inside of the (banana) bend but could also be restricted by incipient buckling of the stent matrix at some point on the matrix. Clearly, to obtain benefit from the present invention, the stent matrix to which it is to be applied must be capable of bending without buckling, to the extent needed to bring the benefits of the present invention into play. In general, the sparser the population of connectors, the more capacity the lattice will have to bend without buckling.
For a better understanding of the present invention, and to show more clearly how the same may be carried into effect, reference will now be made, by way of example, to the accompanying drawings, in which:
Looking first at
In consequence, when the stent in its expanded configuration is subject to longitudinal compression, or when it is bent sharply (so that its longitudinal axis is not longer straight but arcuate) the facing apex portions on the inside of the bend, or that approach each other as the stent is longitudinally compressed do not butt up against each other but, instead, move into the free gap between two spaced apart apex portions of the other of the two facing stenting rings.
In US/2003/0055485, paragraph 0031, it is stated that the geometry of the stent in the radially compact delivery disposition of
We turn now to
Nevertheless, we see from
The offset is accomplished by providing a range of different strut lengths in any particular stenting ring. In particular, each connector 24 is at the apex of a first pair of relatively long struts and a second pair of relatively short struts. Each stenting ring features struts of three different lengths, namely A) short, B) intermediate length and C) long. And we see from
In the compact disposition of the stent of
The present applicant specialises in self-expanding stent devices that are formed from a tubular workpiece of nickel titanium shape memory alloy (“NITINOL” trademark). The tube is formed into a stent precursor by forming in it a multiplicity of slits (cut by a laser) that it is convenient to provide all mutually parallel to each other and to the long axis of the tubular workpiece. One such construction can be seen in
One embodiment of the present invention, which does succeed in setting the facing points of inflection of adjacent stenting rings circumferentially offset from each other, will now be described be reference to drawings
Noteworthy in
Turning our attention to the next adjacent pair of facing circles F and G in
Nevertheless, the present invention is attractive, when taken in the context of balancing conflicting constraints on the stent designer. Looking at
Reference is now made to
In
The embodiments illustrated in
In this context, we incorporate, by reference to it, the disclosure of WO2001/076508, from the present applicant, which explains how particular strut configurations can be created by using a jig to hold the workpiece in a particular desired configuration during the heat treatment which “sets” the “remembered” configuration of the struts in the shape memory alloy. Thinking along these lines, one could use instead of struts of different lengths a jig that holds the struts in a configuration such as is shown in
When thinking of workpieces of every day household dimensions, such as how to prevent a door opening too far, one would use a strut between the door and the frame that has a set length corresponding to the maximum opening that one wishes to impose on the door. In the same way, one could envisage some sort of collapsing tie to impose a maximum size on the gap between points of inflection 92A and 92D, that extends between the respective struts between the slit 90. Of course, stents are very small, but by no means as small as the nanometer dimensions that are in the minds of designers of medical devices, so there seems no justification for dismissing such tie pieces as impracticable. The reality is that, as stent designs become ever more sophisticated, so the range of applications for stents becomes ever greater and, with that, the demand for stents to mimic ever more closely the flexible behaviour of the original bodily tissue, especially when called upon, from time to time, to bend tightly along its length. The challenge is to build a stent that is strong enough to perform the stenting function which is after all the reason for its surgical implantation in the body while, at the same time, rendering the prosthesis as soft and bendy as possible in all other aspects. The present invention makes a valuable contribution to this objective.
Stents need not be made of nickel titanium alloy. Another biologically compatible material familiar to stent designers is stainless steel. Great efforts are currently being made to use other materials such as biologically compatible polymers. All such stents can benefit from the present invention regardless how they are formed. The illustrated embodiments are not limiting.
Stents need not display the same strut matrix over their entire length. We envisage embodiments in which only part of the length of the prosthesis is given the high flexibility of the present invention. Thus, there may be some turns of the stent matrix that include stagger zones, to deliver flexibility, and other parts of the length of the stent (e.g. end zones, or a mid-length portion) where high flexibility is contra-indicated, and so no stagger zones need be provided in these parts of the stent matrix.
Number | Date | Country | Kind |
---|---|---|---|
PCT/EP07/04407 | May 2006 | WO | international |
This application is a continuation of U.S. patent application Ser. No. 12/300,985, filed as a U.S. national stage application under 35 USC §371 of International Application No. PCT/EP2007/004407, filed May 16, 2007, now U.S. Pat. No. 8,403,978, which claims priority to United Kingdom Patent Application No. 0609841.2, filed May 17, 2006, each of which is incorporated by reference in its entirety into this application.
Number | Name | Date | Kind |
---|---|---|---|
5091205 | Fan | Feb 1992 | A |
5464419 | Glastra | Nov 1995 | A |
5527353 | Schmitt | Jun 1996 | A |
5591223 | Lock et al. | Jan 1997 | A |
5645532 | Horgan | Jul 1997 | A |
5725572 | Lam et al. | Mar 1998 | A |
5741327 | Frantzen | Apr 1998 | A |
5759192 | Saunders | Jun 1998 | A |
5800511 | Mayer | Sep 1998 | A |
5824042 | Lombardi et al. | Oct 1998 | A |
5824059 | Wijay | Oct 1998 | A |
5824077 | Mayer | Oct 1998 | A |
5843118 | Sepetka et al. | Dec 1998 | A |
5858556 | Eckert et al. | Jan 1999 | A |
5861027 | Trapp | Jan 1999 | A |
5868783 | Tower | Feb 1999 | A |
5922020 | Klein et al. | Jul 1999 | A |
6022374 | Imran | Feb 2000 | A |
6053940 | Wijay | Apr 2000 | A |
6056187 | Acciai et al. | May 2000 | A |
6086611 | Duffy et al. | Jul 2000 | A |
6099561 | Alt | Aug 2000 | A |
6174329 | Callol et al. | Jan 2001 | B1 |
6241762 | Shanley | Jun 2001 | B1 |
6270524 | Kim | Aug 2001 | B1 |
6293966 | Frantzen | Sep 2001 | B1 |
6312456 | Kranz et al. | Nov 2001 | B1 |
6334871 | Dor et al. | Jan 2002 | B1 |
6355057 | DeMarais et al. | Mar 2002 | B1 |
6379381 | Hossainy et al. | Apr 2002 | B1 |
6387123 | Jacobs et al. | May 2002 | B1 |
6409752 | Boatman et al. | Jun 2002 | B1 |
6451047 | McCrea et al. | Sep 2002 | B2 |
6471721 | Dang | Oct 2002 | B1 |
6475233 | Trozera | Nov 2002 | B2 |
6478816 | Kveen et al. | Nov 2002 | B1 |
6540777 | Stenzel et al. | Apr 2003 | B2 |
6547818 | Rourke et al. | Apr 2003 | B1 |
6562065 | Shanley | May 2003 | B1 |
6585757 | Callol | Jul 2003 | B1 |
6605110 | Harrison | Aug 2003 | B2 |
6629994 | Gomez et al. | Oct 2003 | B2 |
6676700 | Jacobs et al. | Jan 2004 | B1 |
6770089 | Hong et al. | Aug 2004 | B1 |
6797217 | McCrea et al. | Sep 2004 | B2 |
6827734 | Fariabi | Dec 2004 | B2 |
6878162 | Bales et al. | Apr 2005 | B2 |
6979346 | Hossainy et al. | Dec 2005 | B1 |
7060093 | Dang et al. | Jun 2006 | B2 |
7135038 | Limon | Nov 2006 | B1 |
7175654 | Bonsignore et al. | Feb 2007 | B2 |
7381217 | Tischler | Jun 2008 | B2 |
7462190 | Lombardi | Dec 2008 | B2 |
7468071 | Edwin et al. | Dec 2008 | B2 |
7479157 | Weber et al. | Jan 2009 | B2 |
7691461 | Prabhu | Apr 2010 | B1 |
7771463 | Ton et al. | Aug 2010 | B2 |
7772659 | Rodmacq et al. | Aug 2010 | B2 |
8043364 | Lombardi et al. | Oct 2011 | B2 |
8152842 | Schlun | Apr 2012 | B2 |
8292950 | Dorn et al. | Oct 2012 | B2 |
8322593 | Wack | Dec 2012 | B2 |
8403978 | Schlun et al. | Mar 2013 | B2 |
8475520 | Wack et al. | Jul 2013 | B2 |
8500793 | Zipse et al. | Aug 2013 | B2 |
8518101 | Dreher | Aug 2013 | B2 |
8551156 | Wack et al. | Oct 2013 | B2 |
20020007212 | Brown et al. | Jan 2002 | A1 |
20020116044 | Cottone et al. | Aug 2002 | A1 |
20020116051 | Cragg | Aug 2002 | A1 |
20020138136 | Chandresekaran et al. | Sep 2002 | A1 |
20020193867 | Gladdish et al. | Dec 2002 | A1 |
20020193869 | Dang | Dec 2002 | A1 |
20020198589 | Leong | Dec 2002 | A1 |
20030055485 | Lee et al. | Mar 2003 | A1 |
20030135254 | Curcio et al. | Jul 2003 | A1 |
20030144725 | Lombardi | Jul 2003 | A1 |
20030216807 | Jones et al. | Nov 2003 | A1 |
20030225448 | Gerberding | Dec 2003 | A1 |
20040015228 | Lombardi et al. | Jan 2004 | A1 |
20040015229 | Fulkerson et al. | Jan 2004 | A1 |
20040034402 | Bales et al. | Feb 2004 | A1 |
20040044401 | Bales et al. | Mar 2004 | A1 |
20040073290 | Chouinard | Apr 2004 | A1 |
20040073291 | Brown et al. | Apr 2004 | A1 |
20040088043 | Klein | May 2004 | A1 |
20040117002 | Girton et al. | Jun 2004 | A1 |
20040230293 | Yip et al. | Nov 2004 | A1 |
20040236400 | Edwin et al. | Nov 2004 | A1 |
20040236409 | Pelton et al. | Nov 2004 | A1 |
20040254637 | Yang et al. | Dec 2004 | A1 |
20050049682 | Leanna et al. | Mar 2005 | A1 |
20050060025 | Mackiewicz et al. | Mar 2005 | A1 |
20050149168 | Gregorich | Jul 2005 | A1 |
20050172471 | Vietmeier | Aug 2005 | A1 |
20050182477 | White | Aug 2005 | A1 |
20050184277 | Su et al. | Aug 2005 | A1 |
20050222667 | Hunt | Oct 2005 | A1 |
20050278019 | Gregorich | Dec 2005 | A1 |
20060030934 | Hogendijk et al. | Feb 2006 | A1 |
20060064153 | Langhans et al. | Mar 2006 | A1 |
20060216431 | Kerrigan | Sep 2006 | A1 |
20060241741 | Lootz | Oct 2006 | A1 |
20060253187 | Moriuchi et al. | Nov 2006 | A1 |
20060265049 | Gray et al. | Nov 2006 | A1 |
20070112421 | O'Brien | May 2007 | A1 |
20070219624 | Brown et al. | Sep 2007 | A1 |
20080051885 | Llanos et al. | Feb 2008 | A1 |
20080188924 | Prabhu | Aug 2008 | A1 |
20090125092 | McCrea et al. | May 2009 | A1 |
20090125099 | Weber et al. | May 2009 | A1 |
20090200360 | Wack | Aug 2009 | A1 |
20090204201 | Wack | Aug 2009 | A1 |
20090204203 | Allen et al. | Aug 2009 | A1 |
20090264982 | Krause et al. | Oct 2009 | A1 |
20100016949 | Wack | Jan 2010 | A1 |
20100070021 | Wack et al. | Mar 2010 | A1 |
20100114298 | Dorn et al. | May 2010 | A1 |
20100191321 | Schlun et al. | Jul 2010 | A1 |
20100204784 | Molaei et al. | Aug 2010 | A1 |
20100211161 | Dreher | Aug 2010 | A1 |
20100234936 | Schlun | Sep 2010 | A1 |
20100249903 | Wack et al. | Sep 2010 | A1 |
20100298921 | Schlun et al. | Nov 2010 | A1 |
20110196473 | McCrea et al. | Aug 2011 | A1 |
20110198327 | Prabhu | Aug 2011 | A1 |
20110245905 | Weber et al. | Oct 2011 | A1 |
20110319977 | Pandelidis et al. | Dec 2011 | A1 |
20120041542 | Lombardi et al. | Feb 2012 | A1 |
Number | Date | Country |
---|---|---|
04130431 | Mar 1993 | DE |
29621207 | Jan 1997 | DE |
19728337 | Jan 1999 | DE |
29904817 | May 1999 | DE |
10201151 | Jul 2003 | DE |
202004014789 | Jan 2005 | DE |
102004045994 | Mar 2006 | DE |
0481365 | Apr 1992 | EP |
0709068 | May 1996 | EP |
0800800 | Oct 1997 | EP |
0847733 | Jun 1998 | EP |
0870483 | Oct 1998 | EP |
1029517 | Aug 2000 | EP |
1034751 | Sep 2000 | EP |
1157673 | Nov 2001 | EP |
1190685 | Mar 2002 | EP |
1212991 | Jun 2002 | EP |
1245203 | Oct 2002 | EP |
1255507 | Nov 2002 | EP |
1356789 | Oct 2003 | EP |
1433438 | Jun 2004 | EP |
1488763 | Dec 2004 | EP |
1767240 | Mar 2007 | EP |
2134301 | Dec 2009 | EP |
2626046 | Jul 1989 | FR |
453944 | Sep 1936 | GB |
07315147 | Dec 1995 | JP |
2004-506477 | Mar 2004 | JP |
2007-504891 | Mar 2007 | JP |
4827965 | Nov 2011 | JP |
4933018 | May 2012 | JP |
9417754 | Aug 1994 | WO |
9503010 | Feb 1995 | WO |
9626689 | Sep 1996 | WO |
9733534 | Sep 1997 | WO |
9820810 | May 1998 | WO |
9915108 | Apr 1999 | WO |
9938457 | Aug 1999 | WO |
9949928 | Oct 1999 | WO |
9955253 | Nov 1999 | WO |
0045742 | Aug 2000 | WO |
0049971 | Aug 2000 | WO |
0064375 | Nov 2000 | WO |
0132102 | May 2001 | WO |
0158384 | Aug 2001 | WO |
0176508 | Oct 2001 | WO |
0101889 | Nov 2001 | WO |
0215820 | Feb 2002 | WO |
0249544 | Jun 2002 | WO |
03055414 | Jul 2003 | WO |
03075797 | Sep 2003 | WO |
03101343 | Dec 2003 | WO |
2004019820 | Mar 2004 | WO |
2004028408 | Apr 2004 | WO |
2004032802 | Apr 2004 | WO |
2004058384 | Jul 2004 | WO |
2005067816 | Jul 2005 | WO |
2005072652 | Aug 2005 | WO |
2005104991 | Nov 2005 | WO |
2005032403 | Dec 2005 | WO |
2006010636 | Feb 2006 | WO |
2006010638 | Feb 2006 | WO |
2006014768 | Feb 2006 | WO |
2006025847 | Mar 2006 | WO |
2006036912 | Apr 2006 | WO |
2006047977 | May 2006 | WO |
2006064153 | Jun 2006 | WO |
2007073413 | Jun 2007 | WO |
2006026778 | Nov 2007 | WO |
2007131798 | Nov 2007 | WO |
2007135090 | Nov 2007 | WO |
2008006830 | Jan 2008 | WO |
2008022949 | Feb 2008 | WO |
2008022950 | Feb 2008 | WO |
2008025762 | Mar 2008 | WO |
2008028964 | Mar 2008 | WO |
2008055980 | May 2008 | WO |
2008068279 | Jun 2008 | WO |
2008101987 | Aug 2008 | WO |
2008119837 | Oct 2008 | WO |
2009030748 | Mar 2009 | WO |
Entry |
---|
U.S. Appl. No. 10/362,040, filed Jun. 27, 2003 Office Action dated Aug. 2, 2006. |
U.S. Appl. No. 10/362,040, filed Jun. 27, 2003 Office Action dated Dec. 10, 2007. |
U.S. Appl. No. 10/362,040, filed Jun. 27, 2003 Office Action dated Feb. 23, 2010. |
U.S. Appl. No. 10/362,040, filed Jun. 27, 2003 Office Action dated Jan. 10, 2006. |
U.S. Appl. No. 10/362,040, filed Jun. 27, 2003 Office Action dated Jul. 15, 2009. |
U.S. Appl. No. 10/362,040, filed Jun. 27, 2003 Office Action dated Jun. 23, 2005. |
U.S. Appl. No. 10/362,040, filed Jun. 27, 2003 Office Action dated Jun. 5, 2007. |
U.S. Appl. No. 12/300,985, filed Aug. 6, 2010 Final Office Action dated Aug. 15, 2012. |
U.S. Appl. No. 12/300,985, filed Aug. 6, 2010 Non-Final Office Action dated Mar. 15, 2012. |
U.S. Appl. No. 12/300,985, filed Aug. 6, 2010 Notice of Allowance dated Nov. 16, 2012. |
U.S. Appl. No. 12/301,019, filed Feb. 2, 2009 Advisory Action dated Apr. 27, 2011. |
U.S. Appl. No. 12/301,019, filed Feb. 2, 2009 Final Office Action dated Feb. 7, 2011. |
U.S. Appl. No. 12/301,019, filed Feb. 2, 2009 Non-Final Office Action dated Sep. 3, 2010. |
U.S. Appl. No. 12/373,116, filed Jul. 14, 2009 Advisory Action dated Jul. 26, 2011. |
U.S. Appl. No. 12/373,116, filed Jul. 14, 2009 Examiner's Answer dated Jan. 3, 2013. |
U.S. Appl. No. 12/373,116, filed Jul. 14, 2009 Final Office Action dated Apr. 27, 2011. |
U.S. Appl. No. 12/373,116, filed Jul. 14, 2009 Final Office Action dated Mar. 29, 2012. |
U.S. Appl. No. 12/373,116, filed Jul. 14, 2009 Non-Final Office Action dated Nov. 10, 2010. |
U.S. Appl. No. 12/373,116, filed Jul. 14, 2009 Non-Final Office Action dated Nov. 18, 2011. |
U.S. Appl. No. 12/373,116, filed Jul. 14, 2009 Notice of Panel Decision dated Aug. 20, 2012. |
U.S. Appl. No. 12/438,102, filed Feb. 19, 2009 Non-Final Office Action dated Nov. 15, 2010. |
U.S. Appl. No. 12/438,330, filed Feb. 20, 2009 Advisory Action dated Oct. 14, 2010. |
U.S. Appl. No. 12/438,330, filed Feb. 20, 2009 Advisory Action dated Oct. 20, 2011. |
U.S. Appl. No. 12/438,330, filed Feb. 20, 2009 Final Office Action dated Aug. 11, 2011. |
U.S. Appl. No. 12/438,330, filed Feb. 20, 2009 Non-Final Office Action dated Jun. 7, 2012. |
U.S. Appl. No. 12/438,330, filed Feb. 20, 2009 Notice of Allowance dated Sep. 25, 2012. |
U.S. Appl. No. 12/438,330, filed Feb. 20, 2009 Office Action dated Aug. 5, 2010. |
U.S. Appl. No. 12/438,330, filed Feb. 20, 2009 Office Action dated Mar. 16, 2010. |
U.S. Appl. No. 12/438,330, filed Feb. 20, 2009 Office Action dated Mar. 4, 2011. |
U.S. Appl. No. 12/438,527, filed Feb. 23, 2009 Advisory Action dated May 24, 2012. |
U.S. Appl. No. 12/438,527, filed Feb. 23, 2009 Final Office Action dated Mar. 7, 2012. |
U.S. Appl. No. 12/438,527, filed Feb. 23, 2009 Non-Final Office Action dated Jul. 11, 2011. |
U.S. Appl. No. 12/440,415, filed Mar. 6, 2009 Final Office Action dated Jan. 10, 2013. |
U.S. Appl. No. 12/440,415, filed Mar. 6, 2009 Non-Final Office Action dated Jul. 2, 2012. |
U.S. Appl. No. 12/514,177, filed May 8, 2009 Advisory Action dated Sep. 10, 2012. |
U.S. Appl. No. 12/514,177, filed May 8, 2009 Final Office Action dated Apr. 27, 2011. |
U.S. Appl. No. 12/514,177, filed May 8, 2009 Final Office Action dated Jul. 11, 2012. |
U.S. Appl. No. 12/514,177, filed May 8, 2009 Non-Final Office Action dated Jan. 5, 2011. |
U.S. Appl. No. 12/514,177, filed May 8, 2009 Non-Final Office Action dated Mar. 13, 2012. |
U.S. Appl. No. 12/517,096, filed Jun. 1, 2009 Final Office Action dated Oct. 31, 2011. |
U.S. Appl. No. 12/517,096, filed Jun. 1, 2009 Non-Final Office Action dated Jun. 18, 2012. |
U.S. Appl. No. 12/517,096, filed Jun. 1, 2009 Non-Final Office Action dated May 6, 2011. |
U.S. Appl. No. 12/517,096, filed Jun. 1, 2009 Non-Final Office Action dated Nov. 28, 2012. |
U.S. Appl. No. 12/517,096, filed Jun. 1, 2009 Notice of Panel Decision dated Mar. 23, 2012. |
U.S. Appl. No. 12/528,289, filed Aug. 26, 2009 Non-Final Office Action dated Jan. 27, 2012. |
U.S. Appl. No. 12/594,531, filed Oct. 2, 2009 Advisory Action dated Jan. 10, 2012. |
U.S. Appl. No. 12/594,531, filed Oct. 2, 2009 Final Office Action dated Nov. 4, 2011. |
U.S. Appl. No. 12/594,531, filed Oct. 2, 2009 Non-Final Office Action dated Dec. 17, 2010. |
U.S. Appl. No. 12/594,531, filed Oct. 2, 2009 Non-Final Office Action dated May 12, 2011. |
U.S. Appl. No. 12/594,531, filed Oct. 2, 2009 Non-Final Office Action dated Oct. 2, 2012. |
Database Wikipedia, Sep. 11, 2007, “Lumen (anatomy)” XP 002453737 abstract. |
EP 07787316.4 filed Jul. 10, 2007 Examination Report dated Dec. 23, 2011. |
EP 07802603.6 filed Aug. 14, 2007 Office Action dated Dec. 13, 2010. |
EP 07820066.4 filed Mar. 31, 2009 Examination Report dated Dec. 27, 2011. |
EP 09177588 filed Aug. 14, 2007 Search Report dated Aug. 12, 2011. |
EP 12174308.2 filed Apr. 3, 2008 European Search Report dated Sep. 10, 2012. |
JP 2010-523512 filed Sep. 5, 2008 Office Action dated Sep. 25, 2012. |
PCT/EP2001/009467 International Preliminary Examination Report Sep. 17, 2002. |
PCT/EP2001/009467 International Search Report dated Feb. 18, 2002. |
PCT/EP2007/004407 filed May 16, 2007 International Preliminary Report on Patentability dated Sep. 29, 2008. |
PCT/EP2007/004407 filed May 16, 2007 Search Report dated Sep. 26, 2007. |
PCT/EP2007/004407 filed May 16, 2007 Written Opinion dated Sep. 26, 2007. |
PCT/EP2007/054822 filed on May 18, 2007 International Preliminary Report on Patentability dated Nov. 18, 2008. |
PCT/EP2007/054822 filed on May 18, 2007 Search Report dated Sep. 18, 2007. |
PCT/EP2007/054822 filed on May 18, 2007 Written Opinion dated Nov. 18, 2008. |
PCT/EP2007/057041 filed Jul. 10, 2007 International Preliminary Report on Patentability dated Jan. 13, 2009. |
PCT/EP2007/057041 filed Jul. 10, 2007 International Search Report dated Oct. 18, 2007. |
PCT/EP2007/057041 filed Jul. 10, 2007 Written Opinion Jan. 10, 2009. |
PCT/EP2007/058415 filed on Aug. 14, 2007 International Preliminary Report on Patentability dated Feb. 24, 2009. |
PCT/EP2007/058415 filed on Aug. 14, 2007 Search Report dated Nov. 30, 2007. |
PCT/EP2007/058415 filed on Aug. 14, 2007 Written Opinion dated Nov. 30, 2007. |
PCT/EP2007/058416 filed Aug. 14, 2007 International Preliminary Report on Patentability dated Feb. 24, 2009. |
PCT/EP2007/058416 filed Aug. 14, 2007 International Search Report dated Nov. 22, 2007. |
PCT/EP2007/058416 filed Aug. 14, 2007 Written Opinion dated Feb. 23, 2009. |
PCT/EP2007/058912 filed on Aug. 28, 2007 International Preliminary Report on Patentability dated Nov. 5, 2008. |
PCT/EP2007/058912 filed on Aug. 28, 2007 Search Report dated Nov. 12, 2007. |
PCT/EP2007/058912 filed on Aug. 28, 2007 Written Opinion dated Nov. 12, 2007. |
PCT/EP2007/059407 filed Sep. 7, 2007 International Preliminary Report on Patentability and Written Opinion dated Mar. 10, 2009. |
PCT/EP2007/059407 filed Sep. 7, 2007 International Search Report dated Jul. 3, 2008. |
PCT/EP2007/059407 filed Sep. 7, 2007 Written Opinion dated Mar. 10, 2009. |
PCT/EP2007/062155 filed on Nov. 9, 2007 Search Report dated Mar. 12. 2008. |
PCT/EP2007/062155 filed on Nov. 9, 2007 Written Opinion dated Mar. 12, 2009. |
PCT/EP2007/062155 filed on Novermber 9, 2007 International Preliminary Report on Patentability dated Oct. 15, 2008. |
PCT/EP2007/063347 filed Dec. 5, 2007 Search Report dated Jun. 10, 2009. |
PCT/EP2007/063347 filed Dec. 5, 2007 Written Opinion mailed Jun. 10, 2009. |
PCT/EP2007/063347 filed on Dec. 5, 2007 Search Report mailed Feb. 4, 2008. |
PCT/EP2008/052121 filed Feb. 21, 2008 International Preliminary Report on Patentability dated Aug. 26, 2009. |
PCT/EP2008/052121 filed Feb. 21, 2008 International Search Report dated May 19, 2008. |
PCT/EP2008/052121 filed Feb. 21, 2008 Written Opinion dated May 9, 2008. |
PCT/EP2008/054007 filed Apr. 3, 2008 International Preliminary Report on Patentability dated Jul. 27, 2009. |
PCT/EP2008/054007 filed Apr. 3, 2008 Search Report dated Jan. 30, 2009. |
PCT/EP2008/054007 filed Apr. 3, 2008 Written Opinion dated Jan. 30, 2009. |
PCT/EP2008/061775 filed Sep. 5, 2008 International Search Report dated Apr. 22, 2009. |
PCT/EP2008/061775 filed Sep. 5, 2008 Written Opinion dated Apr. 22, 2009. |
U.S. Appl. No. 10/362,040, filed Jun. 27, 2003 Advisory Action dated Dec. 16, 2010. |
U.S. Appl. No. 10/362,040, filed Jun. 27, 2003 Advisory Action dated Jan. 9, 2009. |
U.S. Appl. No. 10/362,040, filed Jun. 27, 2003 Advisory Action dated Nov. 29, 2006. |
U.S. Appl. No. 10/362,040, filed Jun. 27, 2003 Final Office Action dated Aug. 30, 2010. |
U.S. Appl. No. 10/362,040, filed Jun. 27, 2003 Notice of Allowance dated Jun. 22, 2011. |
U.S. Appl. No. 10/362,040, filed Jun. 27, 2003 Office Action dated Aug. 18, 2008. |
U.S. Appl. No. 13/279,189, filed Oct. 21, 2011 Non-Final Office Action dated Oct. 17, 2012. |
PCT/EP2007/054822 filed May 16, 2007 International Preliminary Report on Patentability dated Nov. 18, 2008. |
U.S. Appl. No. 12/301,019, filed Feb. 2, 2009 Notice of Allowance dated Jul. 9, 2013. |
U.S. Appl. No. 12/438,102, filed Feb. 19, 2009 Final Office Action dated Apr. 21, 2011. |
U.S. Appl. No. 12/438,102, filed Feb. 19, 2009 Advisory Action dated Jul. 12, 2011. |
U.S. Appl. No. 12/438,102, filed Feb. 19, 2009 Notice of Allowance dated Dec. 6, 2011. |
U.S. Appl. No. 12/438,527, filed Feb. 23, 2009 Non-Final Office Action dated Oct. 9, 2014. |
U.S. Appl. No. 12/438,527, filed Feb. 23, 2009 Final Office Action dated May 14, 2015. |
U.S. Appl. No. 12/440,415, filed Mar. 6, 2009 Notice of Allowance dated Apr. 3, 2013. |
U.S. Appl. No. 12/514,177, filed May 8, 2009 Notice of Allowance dated Jun. 13, 2013. |
U.S. Appl. No. 12/517,096, filed Jun. 1, 2009 Notice of Allowance dated Mar. 18, 2013. |
U.S. Appl. No. 12/528,289, filed Aug. 26, 2009 Notice of Allowance dated Jun. 29, 2012. |
U.S. Appl. No. 12/594,531, filed Oct. 2, 2009 Notice of Allowance dated May 7, 2013. |
U.S. Appl. No. 13/279,189, filed Oct. 21, 2011 Final Office Action dated May 2, 2013. |
U.S. Appl. No. 13/279,189, filed Oct. 21, 2011 Notice of Allowance dated May 6, 2014. |
U.S. Appl. No. 13/402,787, filed Feb. 22, 2012 Notice of Allowance dated Apr. 9, 2013. |
U.S. Appl. No. 14/045,603, filed Oct. 3, 2013 Non-Final Office Action dated Dec. 15, 2014. |
U.S. Appl. No. 14/045,603, filed Oct. 3, 2013 Notice of Allowance dated Mar. 30, 2015. |
U.S. Appl. No. 13/975,147, filed Aug. 23, 2013 Non-Final Office Action dated May 15, 2014. |
U.S. Appl. No. 13/975,147, filed Aug. 23, 2013 Notice of Allowance dated Feb. 11, 2015. |
U.S. Appl. No. 12/676,584, filed Mar. 4, 2010 Non-Final Office Action dated May 24, 2013. |
Number | Date | Country | |
---|---|---|---|
20130218260 A1 | Aug 2013 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12300985 | US | |
Child | 13849312 | US |